Nuclear Medicine Radioisotopes Market Global Insights and Research Report 2020 to 2025 – Medtronic Plc, Ge Healthcare, Lantheus Medical Imaging Inc, Hologic Inc

Nuclear Medicine Radioisotopes market has been thoroughly scrutinized and then carefully demarcated by geographic locations which are based on major economic regions and their topographical regions. Growing competition and the changing market dynamics has been highlighted. Aggressive market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. The Market share and Market size prominent players for 2020 to 2025 are profiled in this report.

The global nuclear medicine radioisotopes market has been estimated to reach USD 13.9 billion in 2017.The market is expected to register a CAGR of 12.3% during the forecast period 2018 to 2023.

The Nuclear Medicine Radioisotopes market is highly competitive and consists of a number of major players. Top Companies like Medtronic Plc, Ge Healthcare, Lantheus Medical Imaging Inc(NASDAQ: LNTH), Hologic Inc, Cardinal Health Inc, Bayer Healthcare Ag, Bracco Imaging Spa, Ntp Radioisotopes Soc Ltd, Positron Corporation And Siemens Healthcare among others

Click the link to get a Sample Copy of the Report:

Scope of the Report

The cost of imaging and treatment overall becomes a factor of high expenditure especially in developing markets. These factors including unclear regulatory guidelines and varied reimbursement policies and short half-life of radiopharmaceuticals restricts the growth of this market

Key Market Trends

Rising SPECT and PET Applications

The field of nuclear medicine is dominated by the applications related to positron emission tomography (PET) and single-photon emission computerized tomography (SPECT). Growing interest of PET technology in cardiac and neurological disorders is expected to fuel the market growth. More than 60% of SPECT procedures are performed in cardiology and in addition, orthopedics, oncology and infection imaging are emerging as areas that can benefit from the same. Applications are further increased through the inclusion of advancements in computed tomography (CT), making nuclear medicine as a rising choice for disease diagnosis. In addition, factors such as rising incidences of cardiac and cancer cases along-with rising awareness of public for the same, drives the nuclear medicine market.

Inquire for Discount:

What are the market factors that are explained in the report?

Key Strategic Developments: The study also includes the key strategic developments of the market, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features: The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, import/export, supply/demand, cost, market share, CAGR, and gross margin. In addition, the study offers a comprehensive study of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments.

Analytical Tools: Nuclear Medicine Radioisotopes Market report includes the accurately studied and assessed data of the key industry players and their scope in the market by means of a number of analytical tools. The analytical tools such as Porter’s five forces analysis, feasibility study, and investment return analysis have been used to analyzed the growth of the key players operating in the market. 

Browse the Full report description and TOC at:

The research includes historic data from 2015 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Media Contact Us:

Irfan Tamboli (Head of Sales) – Market Insights Reports

Phone: + 1704 266 3234 | +91-750-707-8687  |


Leave a Reply

Your email address will not be published. Required fields are marked *